Solta Medical Announces Clear + Brilliant™ Technology Receives Health Canada Approval

Clear + Brilliant creates new category of laser aesthetic treatments

News provided by

Aug 31, 2011, 08:30 ET

HAYWARD, Calif., Aug. 31, 2011 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments, today, announced Health Canada approval of its new Clear + Brilliant laser aesthetic treatment. This technology is now available to physicians in Canada. In May of 2011, the company received FDA 510(K) clearance and CE Mark to market and sell Clear + Brilliant. This revolutionary treatment is an effective treatment based on fractional laser technology that is performed in a professional setting.

The launch of Clear + Brilliant creates and defines an entirely new category of laser aesthetic treatments designed to attract younger patients looking to take control of their aging process. Clear + Brilliant provides a new offering for physicians and skin care providers to address evolving consumer needs and expand their patient base. In-depth research with patients and their skin care providers revealed an unmet need in the skin care continuum that lies between over the counter or spa treatments and more aggressive laser offerings such as Fraxel. These consumers would like a more efficacious treatment than their current regimens, but as of yet they do not need the full transformative benefits of a more aggressive laser skin resurfacing procedure. They are looking for a treatment solution that refreshes their skin, providing a more youthful appearance.

Unlike other conventional lasers that utilize the stamping delivery method, Clear + Brilliant features a patented Intelligent Optical Tracking System that provides consistent coverage and insures a uniformly toned treatment area. Each treatment rejuvenates the skin from the inside out by allowing healthy, younger-looking skin to surface and only takes about 20 minutes per treatment session.

"Solta Medical is committed to strengthening our product portfolio and meeting the needs of skin care professionals and their patients," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "With the Health Canada approval of our Clear + Brilliant system and worldwide distribution of this product, we are able to reach a whole new professional and consumer base. We are excited to see this product expand our patient base and generate incremental revenue for clinicians and for the Company."

ABOUT SOLTA MEDICAL, INC.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's five premier brands: Thermage®, Fraxel®, Isolaz®, CLARO® and Clear + Brilliant®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. Clear + Brilliant is a unique, cost-effective treatment that utilizes safe, fractional laser technology to correct and prevent early signs of aging and is FDA cleared and CE marked. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

SOURCE Solta Medical, Inc.